The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models.

Abstract:

BACKGROUND:Lung cancer is the number one cancer killer worldwide. A major drawback in the lung cancer treatment field is the lack of realistic mouse models that replicate the complexity of human malignancy and immune contexture within the tumor microenvironment. Such models are urgently needed. Mutations of the tumor protein p53 are among the most common alterations in human lung cancers. METHODS:Previously, we developed a line of lung cancer mouse model where mutant human TP53-273H is expressed in a lung specific manner in FVB/N background. To investigate whether the human TP53 mutant has a similar oncogenic potential when it is expressed in another strain of mouse, we crossed the FVB/N-SPC-TP53-273H mice to A/J strain and created A/J-SPC-TP53-273H transgenic mice. We then compared lung tumor formation between A/J-SPC-TP53-273H and FVB/N-SPC-TP53-273H. RESULTS:We found the TP53-273H mutant gene has a similar oncogenic potential in lung tumor formation in both mice strains, although A/J strain mice have been found to be a highly susceptible strain in terms of carcinogen-induced lung cancer. Both transgenic lines survived more than 18 months and developed age related lung adenocarcinomas. With micro CT imaging, we found the FVB-SPC-TP53-273H mice survived more than 8 weeks after initial detection of lung cancer, providing a sufficient window for evaluating new anti-cancer agents. CONCLUSIONS:Oncogenic potential of the most common genetic mutation, TP53-273H, in human lung cancer is unique when it is expressed in different strains of mice. Our mouse models are useful tools for testing novel immune checkpoint inhibitors or other therapeutic strategies in the treatment of lung cancer.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Ramelow J,Brooks CD,Gao L,Almiman AA,Williams TM,Villalona-Calero MA,Duan W

doi

10.1186/s12885-020-07212-6

subject

Has Abstract

pub_date

2020-08-08 00:00:00

pages

738

issue

1

issn

1471-2407

pii

10.1186/s12885-020-07212-6

journal_volume

20

pub_type

杂志文章
  • Amplification of HER2 is a marker for global genomic instability.

    abstract:BACKGROUND:Genomic alterations of the proto-oncogene c-erbB-2 (HER-2/neu) are associated with aggressive behavior and poor prognosis in patients with breast cancer. The variable clinical outcomes seen in patients with similar HER2 status, given similar treatments, suggests that the effects of amplification of HER2 can ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-297

    authors: Ellsworth RE,Ellsworth DL,Patney HL,Deyarmin B,Love B,Hooke JA,Shriver CD

    更新日期:2008-10-14 00:00:00

  • Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study.

    abstract:BACKGROUND:Pelvic inflammatory disease (PID) is characterized by infection and inflammation of the upper genital tract in women and is associated with health sequelae. We used a nationwide population-based retrospective cohort study to explore the relationship between PID and the subsequent development of gynecological...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-016-2857-1

    authors: Shen CC,Hu LY,Yang AC,Chiang YY,Hung JH,Tsai SJ

    更新日期:2016-11-03 00:00:00

  • Impact of chromosomal instability on colorectal cancer progression and outcome.

    abstract:BACKGROUND:It remains presently unclear whether disease progression in colorectal carcinoma (CRC), from early, to invasive and metastatic forms, is associated to a gradual increase in genetic instability and to a scheme of sequentially occurring Copy Number Alterations (CNAs). METHODS:In this work we set to determine ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-121

    authors: Orsetti B,Selves J,Bascoul-Mollevi C,Lasorsa L,Gordien K,Bibeau F,Massemin B,Paraf F,Soubeyran I,Hostein I,Dapremont V,Guimbaud R,Cazaux C,Longy M,Theillet C

    更新日期:2014-02-22 00:00:00

  • If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.

    abstract:BACKGROUND:Staging of B-cell non Hodgkin's lymphoma (NHL) routinely involves bone marrow (BM) examination by trephine biopsy (BM-TB). The evidence of disease in the BM-TB results in a clinical stage IV classification affecting therapeutic strategies for NHL patients. BM immunophenotyping by flow cytometry (FC) is also ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-644

    authors: Mancuso P,Calleri A,Antoniotti P,Quarna J,Pruneri G,Bertolini F

    更新日期:2010-11-24 00:00:00

  • Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma.

    abstract:BACKGROUND:The variable prognosis in stage III cutaneous melanoma is partially due to unknown prognostic factors. Improved prognostic tools are required to define patients with an increased risk of developing metastatic disease who might benefit from adjuvant therapies. The aim was to examine if cellular immune markers...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3577-x

    authors: Falkenius J,Johansson H,Tuominen R,Frostvik Stolt M,Hansson J,Egyhazi Brage S

    更新日期:2017-08-29 00:00:00

  • Return to work after cancer treatment of gynecologic cancer in Japan.

    abstract:BACKGROUND:Gynecologic cancer is one of the most common malignant diseases in working-age women. This study investigated whether several characteristics influence return to work after treatment of gynecologic cancer. METHODS:We investigated the correlations between return to work and several other characteristics in 1...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2627-0

    authors: Nakamura K,Masuyama H,Nishida T,Haraga J,Ida N,Saijo M,Haruma T,Kusumoto T,Seki N,Hiramatsu Y

    更新日期:2016-07-29 00:00:00

  • 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice.

    abstract:BACKGROUND:Colorectal peritoneal carcinomatosis (CRPC) is a common form of systemic metastasis of intra-abdominal cancers. Intraperitoneal chemotherapy is a preferable option for colorectal cancer. Here we reported that a new system, 5-FU-loaded hydrogel system, can improve the therapeutic effects of intraperitoneal ch...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-402

    authors: Wang Y,Gong C,Yang L,Wu Q,Shi S,Shi H,Qian Z,Wei Y

    更新日期:2010-08-02 00:00:00

  • APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology.

    abstract:BACKGROUND:The APC tumor suppressor is mutated or downregulated in many tumor types, and is prominently localized to punctate clusters at protrusion tips in migratory cells, such as in astrocytes where it has been implicated in directed cell motility. Although APC loss is considered an initiating event in colorectal ca...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-12

    authors: Odenwald MA,Prosperi JR,Goss KH

    更新日期:2013-01-09 00:00:00

  • (Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges.

    abstract:BACKGROUND:Sorafenib is an orally active multikinase tyrosine kinase inhibitor (TKI) that targets B-type Raf kinase (BRAF), vascular endothelial growth factor receptors (VEGFR) 1 and 2, and rearranged during transfection (RET), inducing anti-angiogenic and pro-apoptotic actions in a wide range of solid tumors. A side e...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2060-4

    authors: Schneider TC,Kapiteijn E,van Wezel T,Smit JWA,van der Hoeven JJM,Morreau H

    更新日期:2016-01-19 00:00:00

  • Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study.

    abstract:BACKGROUND:Territorial differences in the access to innovative anticancer drugs have been reported from many countries. The objectives of this study were to evaluate access to innovative treatments for metastatic lung cancer in France, and to assess whether socioeconomic indicators were predictors of access at the leve...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4958-5

    authors: Scherpereel A,Durand-Zaleski I,Cotté FE,Fernandes J,Debieuvre D,Blein C,Gaudin AF,Tournier C,Vainchtock A,Chauvin P,Souquet PJ,Westeel V,Chouaïd C

    更新日期:2018-10-22 00:00:00

  • Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.

    abstract:BACKGROUND:To investigate on expressions and clinical significances of CD133 protein and vasculogenic mimicry (VM) in primary non-small cell lung cancer (NSCLC). METHODS:The specimens of NSCLC from 305 Chinese patients with follow-up were analyzed for CD133 protein expression and VM by immunohistochemical and histoche...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-535

    authors: Wu S,Yu L,Wang D,Zhou L,Cheng Z,Chai D,Ma L,Tao Y

    更新日期:2012-11-21 00:00:00

  • Correction to: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).

    abstract::Following publication of the original article [1], the authors reported an error in Figure 2, where the color code of the text boxes is reversed. Figure 2-amended shows the correct color association between the text boxes and the different areas in the map: Navarra, neighbouring communities and other Spanish communiti...

    journal_title:BMC cancer

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s12885-019-6458-7

    authors: de Sabando AR,Lafuente EU,García-Amigot F,Sánchez AA,Garofalo LM,Moreno S,Ardanaz E,Ramos-Arroyo MA

    更新日期:2019-12-17 00:00:00

  • Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.

    abstract:BACKGROUND:Maintenance of quality of life is the primary goal during treatment of brain metastases (BM). This is a protocol of an ongoing phase III randomised multicentre study. This study aims to determine the exact additional palliative value of stereotactic radiosurgery (SRS) over whole brain radiotherapy (WBRT) in ...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-017-3494-z

    authors: Zindler JD,Bruynzeel AME,Eekers DBP,Hurkmans CW,Swinnen A,Lambin P

    更新日期:2017-07-25 00:00:00

  • Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis.

    abstract:BACKGROUND:cMyc and p27 are key genes implicated in carcinogenesis. Whether polymorphisms in these genes affect breast cancer risk or prognosis is still unclear. In this study, we focus on a rare non-synonymous polymorphism in cMyc (N11S) and a common polymorphism in p27 (V109G) and determine their role in risk and pro...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-99

    authors: Figueiredo JC,Knight JA,Cho S,Savas S,Onay UV,Briollais L,Goodwin PJ,McLaughlin JR,Andrulis IL,Ozcelik H

    更新日期:2007-06-14 00:00:00

  • Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition.

    abstract:BACKGROUND:Activating transcription factor-3 (ATF3) is involved in the complex process of cellular stress response. However, its exact role in cancer is discussed controversially because both tumor suppressive and oncogenic effects have been described. Here we followed-up on our previous observation that inhibition of ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-668

    authors: Hackl C,Lang SA,Moser C,Mori A,Fichtner-Feigl S,Hellerbrand C,Dietmeier W,Schlitt HJ,Geissler EK,Stoeltzing O

    更新日期:2010-12-03 00:00:00

  • Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.

    abstract:BACKGROUND:Lymphangiogenesis has become a new research frontier in tumor metastasis since the discovery of reliable lymphatic markers that have allowed observation and isolation of lymphatic endothelium. Cyclooxygenase-2 (COX-2) has been reported to be involved in the critical steps in carcinogenesis. However, possible...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-4

    authors: Zhang XH,Huang DP,Guo GL,Chen GR,Zhang HX,Wan L,Chen SY

    更新日期:2008-01-13 00:00:00

  • The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo.

    abstract:BACKGROUND:Malignant glioma is a common primary tumor of the central nervous system. Brevican, an abundant extracellular matrix component in the adult brain, plays a critical role in the process of glioma. The mechanisms for the highly invasive behavior of gliomas are still poorly understood. The aim of this study was ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-607

    authors: Lu R,Wu C,Guo L,Liu Y,Mo W,Wang H,Ding J,Wong ET,Yu M

    更新日期:2012-12-19 00:00:00

  • KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma.

    abstract:BACKGROUND:Our previous cDNA array results indicated KIAA0101 as one of the differentially expressed genes in human hepatocellular carcinoma (HCC) as compared with non-cancerous liver. However, it is necessary to study its expression at protein level in HCC and its biological function for HCC cell growth. METHOD:Weste...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-109

    authors: Guo M,Li J,Wan D,Gu J

    更新日期:2006-04-29 00:00:00

  • Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer.

    abstract:BACKGROUND:Esophageal squamous cell carcinoma (ESCC) is a genetically complex tumor type and a major cause of cancer related mortality. Although distinct genetic alterations have been linked to ESCC development and prognosis, the genetic alterations have not gained clinical applicability. We applied array-based compara...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-98

    authors: Carneiro A,Isinger A,Karlsson A,Johansson J,Jönsson G,Bendahl PO,Falkenback D,Halvarsson B,Nilbert M

    更新日期:2008-04-11 00:00:00

  • Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report.

    abstract:BACKGROUND:Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract and liver and peritoneum are the main sites of recurrence. Ovarian metastases from GIST are very rare. CASE PRESENTATION:A 50 years-old woman was found to have a pelvic mass on transvaginal ultrasound...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4204-1

    authors: De Leo A,Nannini M,Dondi G,Santini D,Urbini M,Gruppioni E,De Iaco P,Perrone AM,Pantaleo MA

    更新日期:2018-03-16 00:00:00

  • Lung cancer treatment and mortality for Aboriginal people in New South Wales, Australia: results from a population-based record linkage study and medical record audit.

    abstract:BACKGROUND:The aim of this study was to compare surgical treatment received by Aboriginal and non-Aboriginal people with non-small cell lung cancer (NSCLC) in New South Wales (NSW), Australia and to examine whether patient and disease characteristics are associated with any disparities found. An additional objective wa...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2322-1

    authors: Gibberd A,Supramaniam R,Dillon A,Armstrong BK,O'Connell DL

    更新日期:2016-04-25 00:00:00

  • Study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA).

    abstract:BACKGROUND:Exercise has favorable effects on biomarkers associated with a lower risk of breast cancer, however it is unclear if higher doses of exercise provide additional effects. No clinical trial has systematically examined how different exercise volumes influence the mechanisms underlying breast cancer etiology. Th...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/1471-2407-14-919

    authors: Friedenreich CM,MacLaughlin S,Neilson HK,Stanczyk FZ,Yasui Y,Duha A,Lynch BM,Kallal C,Courneya KS

    更新日期:2014-12-06 00:00:00

  • Analysis of genetic copy number changes in cervical disease progression.

    abstract:BACKGROUND:Cervical dysplasia and tumorigenesis have been linked with numerous chromosomal aberrations. The goal of this study was to evaluate 35 genomic regions associated with cervical disease and to select those which were found to have the highest frequency of aberration for use as probes in fluorescent in-situ hyb...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-432

    authors: Policht FA,Song M,Sitailo S,O'Hare A,Ashfaq R,Muller CY,Morrison LE,King W,Sokolova IA

    更新日期:2010-08-16 00:00:00

  • Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.

    abstract:BACKGROUND:In Chile, more than 500 women die every year from cervical cancer, and a majority of Chilean women are not up-to-date with their Papanicolau (Pap) test. Mobile health has great potential in many health areas, particularly in health promotion and prevention. There are no randomized controlled trials in Latin ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3870-8

    authors: Momany MC,Martinez-Gutierrez J,Soto M,Capurro D,Ciampi F,Thompson B,Puschel K

    更新日期:2017-12-13 00:00:00

  • Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis.

    abstract:BACKGROUND:Vascular endothelial growth factor (VEGF) is a potent mitogen for endothelial cells, and its expression has been correlated with increased tumour angiogenesis. Although numerous publications dealing with the measurement of circulating VEGF for diagnostic and therapeutic monitoring have been published, the re...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-128

    authors: Cressey R,Wattananupong O,Lertprasertsuke N,Vinitketkumnuen U

    更新日期:2005-10-04 00:00:00

  • Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial.

    abstract:BACKGROUND:There is no consensus on the therapeutic approach to ECOG 2 patients with locally advanced non-small-cell lung cancer (LA-NSCLC), despite the sizable percentage of these patients in clinical practice. This study focused on the efficacy, toxicity and the optimal chemotherapy regimen of CCRT in ECOG 2 patients...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06780-x

    authors: Bi N,Liu L,Liang J,Wu S,Chen M,Lv C,Zhao L,Shi A,Jiang W,Xu Y,Zhou Z,Wang J,Wang W,Chen D,Hui Z,Lv J,Zhang H,Feng Q,Xiao Z,Wang X,Zhang T,Yin W,Li J,He J,Wang L

    更新日期:2020-04-06 00:00:00

  • Kaposi's sarcoma of the conjunctiva and the eyelid leads to the diagnosis of human immunodeficiency virus infection - a case report.

    abstract:BACKGROUND:The purpose of this case report is to describe a conjunctiva and eyelid Kaposi's sarcoma (KS) as the initial manifestation of acquired immunodeficiency syndrome (AIDS), which led to the diagnosis of HIV infection. There are only 3 reported cases of ocular KS as an initial manifestation of HIV infection. CAS...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4611-3

    authors: Sousa Neves F,Braga J,Cardoso da Costa J,Sequeira J,Prazeres S

    更新日期:2018-07-03 00:00:00

  • MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3α.

    abstract:BACKGROUND:Hypoxia is often encountered in solid tumors and known to contribute to aggressive tumor behavior, radiation- and chemotherapy resistance resulting in a poor prognosis for the cancer patient. MicroRNAs (miRNAs) play a role in the regulation of the tumor cell response to hypoxia, however, not much is known ab...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-429

    authors: Gits CM,van Kuijk PF,de Rijck JC,Muskens N,Jonkers MB,van IJcken WF,Mathijssen RH,Verweij J,Sleijfer S,Wiemer EA

    更新日期:2014-06-13 00:00:00

  • A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours.

    abstract:BACKGROUND:Mounting evidence demonstrates a causal role for S100 proteins in tumourigenesis and several S100 isoforms have shown utility as biomarkers of several types of cancer. The S100 family is comprised of 21 small isoforms, many of them implicated in important cellular functions such as proliferation, motility an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1217-x

    authors: Martínez-Aguilar J,Clifton-Bligh R,Molloy MP

    更新日期:2015-03-29 00:00:00

  • Disclosure in lesbian, gay and bisexual cancer care: towards a salutogenic healthcare environment.

    abstract:BACKGROUND:The literature on sexual orientation disclosure is arguably one of the most developed in the field of lesbian, gay and bisexual (LGB) people in healthcare in English speaking countries however, relatively little research has been conducted into disclosure in cancer care. Studies have been mainly undertaken i...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5895-7

    authors: Fish J,Williamson I,Brown J

    更新日期:2019-07-10 00:00:00